Results 121 to 130 of about 19,727 (209)

Mechanism of SARS-CoV-2 resistance to nucleotide analog-based antivirals. [PDF]

Nat Commun
Liu C, Li Y, Cao X, Gleason RJ, Liu B, Yang Y.   +5 more
europepmc   +1 more source

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Teymourzadeh E, Salesi M, Keshavarz K, Abyazi MA, Heiat M, Alavian SM.   +7 more
europepmc   +1 more source

Association between LDL-R (exon 8 C.1171 G > A) polymorphisms and response to antiviral therapy in hepatitis C virus infection. [PDF]

Sci Rep
Shikhoun MEH, Ibrahim HAM, Abeed AAO.
europepmc   +1 more source

Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-naïve Cameroonian patients. [PDF]

IJID Reg
Mounchili-Njifon A, Modiyinji AF, Mbouyap PR, Monamele CG, Moumbeket-Yifomnjou MH, Mfombouot PHN, Machuetum GL, Toueyem PI, Lissock SF, Tagnouokam-Ngoupo PA, Assam JPA, Njouom R.   +11 more
europepmc   +1 more source

Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort. [PDF]

Sci Rep
Suda G, Baba M, Yamamoto Y, Yoshida S, Muranaka T, Meguro T, Terashita K, Ito J, Kobayashi T, Izumi T, Takagi T, Hosoda S, Yamada R, Fu Q, Yang Z, Yokoyama D, Tanaka T, Meno A, Yasuura N, Kitagataya T, Ohara M, Kawagishi N, Nakai M, Sho T, Ogawa K, Sakamoto N.   +25 more
europepmc   +1 more source

Global policy and access to new hepatitis C therapies for people who inject drugs [PDF]

, 2015
Aspinall, Esther, Doyle, Joseph S., Gore, Charles, Hellard, Margaret E., Hutchinson, Sharon, Quinn, Brendan, Wiktor, Stefan   +6 more
core   +1 more source

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

Necrolytic acral erythema in an incarcerated population: A case series. [PDF]

JAAD Case Rep
Ali I, Cavanagh M, Kelly BC.
europepmc   +1 more source

2025 KASL clinical practice guidelines for management of hepatitis C. [PDF]

Clin Mol Hepatol
Jang ES, Heo NY, Jeong JY, Park JG, Song DS, Cho EJ, Lee CH, Lee JS, Yoon JH, Han SK, Jung YK, Korean Association for the Study of the Liver (KASL).   +11 more
europepmc   +1 more source

[Recent Advances in the Treatment of Chronic Hepatitis C]. [PDF]

Korean J Gastroenterol
Kim SB.
europepmc   +1 more source